The Beachbody Company, Inc. (BODI)
NASDAQ: BODI · Real-Time Price · USD
16.05
+0.76 (4.97%)
At close: Apr 28, 2026, 4:00 PM EDT
14.91
-1.14 (-7.08%)
After-hours: Apr 28, 2026, 4:32 PM EDT

Company Description

The Beachbody Company, Inc. operates as a fitness and nutrition company in the United States, Canada, the United Kingdom, and France.

The company operates Beachbody on Demand Interactive, a streaming service through subscription that provides fitness and nutrition content, including P90X, Insanity, 21 Day Fix, 80 Day Obsession, Morning Meltdown 100, LIIFT4, Unstress Meditations, Portion Fix, 4 Weeks of Focus, Sure Thing, Dig Deeper, Track Pilate, 2B Mindset, Insanity, P90X, Yoga52, and other brands.

It also provides nutritional products, such as Shakeology, a nutrition shake; and Beachbody Performance supplements comprising pre-workout energize, hydrate, post-workout recover.

The Beachbody Company, Inc. was founded in 1998 and is headquartered in El Segundo, California.

The Beachbody Company, Inc.
The Beachbody Company logo
Country United States
Founded 1998
Industry Internet Content & Information
Sector Communication Services
Employees 270
CEO Carl Daikeler

Contact Details

Address:
400 Continental Blvd, Floor 6
El Segundo, California 90245
United States
Phone 310 883 9000
Website thebeachbodycompany.com

Stock Details

Ticker Symbol BODI
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001826889
CUSIP Number 073463309
ISIN Number US0734633094
SIC Code 5960

Key Executives

Name Position
Carl D. Daikeler Co-Founder, Chief Executive Officer and Director
Mark R. Goldston Executive Chairman
Brad Ramberg Interim Chief Financial Officer
Kit Q. Boyd Chief Supply Chain Officer
Christina Cartwright Senior Vice President of Nutrition
Brendon Burchard Chief Growth and Performance Advisor
Jonathan Gelfand Executive Vice President of Business and Legal Affairs, Talent Management. Corporate Secretary and IP Development

Latest SEC Filings

Date Type Title
Apr 22, 2026 ARS Filing
Apr 22, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 22, 2026 DEF 14A Other definitive proxy statements
Mar 10, 2026 424B3 Prospectus
Mar 10, 2026 424B3 Prospectus
Mar 10, 2026 10-K Annual Report
Mar 10, 2026 8-K Current Report
Jan 16, 2026 SCHEDULE 13G/A Filing
Jan 8, 2026 8-K Current Report
Nov 10, 2025 424B3 Prospectus